Biggest changeGeneral and administrative expenses are not allocated to the reportable segments: Home Health and Hospice Services Senior Living Services All Other Total Year Ended December 31, 2024 Segment Revenue $ 515,344 $ 174,767 $ 5,129 $ 695,240 Segment Cost of Services 427,635 123,107 Segment Adjusted EBITDAR from Operations $ 87,709 $ 51,660 $ 139,369 Year Ended December 31, 2023 Segment Revenue $ 385,652 $ 148,198 $ 11,041 $ 544,891 Segment Cost of Services 320,046 102,904 Segment Adjusted EBITDAR from Operations $ 65,606 $ 45,294 $ 110,900 Year Ended December 31, 2022 Segment Revenue $ 337,371 $ 126,758 $ 9,112 $ 473,241 Segment Cost of Services 275,544 89,195 Segment Adjusted EBITDAR from Operations $ 61,827 $ 37,563 $ 99,390 The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations: 2024 2023 2022 Segment Adjusted EBITDAR from Operations (a) $ 139,369 $ 110,900 $ 99,390 Less: Unallocated corporate expenses 43,587 31,704 31,435 Less: Depreciation and amortization 6,119 5,130 4,900 Rent—cost of services 43,029 39,759 38,018 Other income 207 339 (31) Adjustments to Segment EBITDAR from Operations: Less: Costs at start-up operations (b) 137 102 1,435 Share-based compensation expense (c) 8,242 5,565 3,363 Acquisition related costs and credit allowances (d) 1,278 476 731 Costs associated with transitioning operations (e) (570) 612 6,103 Unusual, non-recurring or redundant charges (f) 1,004 2,575 1,297 Add: Net income attributable to noncontrolling interest 1,780 531 600 Income from operations $ 38,116 $ 25,169 $ 12,739 35 Table of Contents (a) Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, unallocated corporate and administrative expenses, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation expense, (3) acquisition related costs and credit allowances, (4) costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income (loss) attributable to noncontrolling interest.
Biggest changeGeneral and administrative expenses are not allocated to the reportable segments: Home Health and Hospice Services Senior Living Services All Other Total Year Ended December 31, 2025 Segment Revenue $ 731,392 $ 210,078 $ 6,235 $ 947,705 Segment Cost of Services 610,561 149,553 Segment Adjusted EBITDAR from Operations $ 120,831 $ 60,525 $ 181,356 Year Ended December 31, 2024 Segment Revenue $ 515,344 $ 174,767 $ 5,129 $ 695,240 Segment Cost of Services 427,635 123,107 Segment Adjusted EBITDAR from Operations $ 87,709 $ 51,660 $ 139,369 Year Ended December 31, 2023 Segment Revenue $ 385,652 $ 148,198 $ 11,041 $ 544,891 Segment Cost of Services 320,046 102,904 Segment Adjusted EBITDAR from Operations $ 65,606 $ 45,294 $ 110,900 The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations: Year Ended December 31, 2025 2024 2023 Segment Adjusted EBITDAR from Operations (a) $ 181,356 $ 139,369 $ 110,900 Less: Unallocated corporate expenses 60,455 43,587 31,704 Less: Depreciation and amortization 8,538 6,119 5,130 Rent—cost of services 48,700 43,029 39,759 Other income 422 207 339 Adjustments to Segment EBITDAR from Operations: Less: Start-up operations (b) 182 137 102 Share-based compensation expense (c) 9,036 8,242 5,565 Acquisition related costs (d) 6,587 1,278 476 Activities associated with transitioning operations (e) (880) (570) 612 Transition services costs (f) 503 — — Unusual, non-recurring, or redundant charges (g) 113 1,004 2,575 Add: Net income attributable to noncontrolling interest 4,186 1,780 531 Income from operations $ 51,886 $ 38,116 $ 25,169 35 Table of Contents (a) Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, unallocated corporate and administrative expenses, and, in order to view the operations’ performance on a comparable basis from period to period, certain adjustments including: (1) activities associated with start-up operations, (2) share-based compensation expense, (3) acquisition related costs, (4) activities associated with transitioning operations, (5) transition services costs, (6) unusual, non-recurring, or redundant charges, and (7) net income attributable to noncontrolling interest.
Revolving Credit Facility On July 31, 2024, Pennant amended and restated its existing credit agreement (as amended, the “Amended Credit Agreement”), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $250.0 million (the “Amended Revolving Credit Facility”).
Credit Agreement On July 31, 2024, Pennant amended and restated its existing credit agreement (as amended, the “Amended Credit Agreement”), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $250.0 million (the “Amended Revolving Credit Facility”).
The PDGM payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a low utilization payment adjustment if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source 31 Table of Contents of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day period of care; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments.
The PDGM payment under the Medicare program is also adjusted for certain variables 32 Table of Contents including, but not limited to: (a) a low utilization payment adjustment if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day period of care; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments.
Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2024, the Company was compliant with all such financial covenants. On October 2, 2024, the Company closed the public offering (the “Offering”) of 4,025 shares of its common stock, $0.001 par value per share (“common stock”).
Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2025, the Company was compliant with all such financial covenants. On October 2, 2024, the Company closed the public offering (the “Offering”) of 4,025 shares of its common stock, $0.001 par value per share (“common stock”).
Depreciation and amortization expense stayed flat as a percentage of total revenue. 42 Table of Contents (Gain) loss on Asset Dispositions and Impairment, Net.
Depreciation and amortization expense stayed flat as a percentage of total revenue. 42 Table of Contents Gain on Asset Dispositions and Impairment, Net.
See Note 14 , Income Taxes , to the Consolidated Financial Statements included elsewhere in this report filed on Form 10-K for further discussion. Comparison of Prior Year Information For a comparison of our results of operations of the fiscal year ended December 31, 2023 as compared to the year ended December 31, 2022 refer to Item 7.
See Note 14 , Income Taxes , to the Consolidated Financial Statements included elsewhere in this report filed on Form 10-K for further discussion. Comparison of Prior Year Information For a comparison of our results of operations of the fiscal year ended December 31, 2024 as compared to the year ended December 31, 2023 refer to Item 7.
As a percentage of revenue, rent — cost of services decreased 110 basis points when compared to the year ended December 31, 2023 due to improved overall sales leverage and performance. General and Administrative Expense.
As a percentage of revenue, rent — cost of services decreased 110 basis points when compared to the year ended December 31, 2024 due to improved overall sales leverage and performance. General and Administrative Expense.
We operate in multiple lines of businesses including home health, hospice and senior living services across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. We also provide home health and hospice operational support through a management service agreement in Connecticut.
We operate in multiple lines of businesses including home health, hospice and senior living services across Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. We also provide home health and hospice operational support through a management service agreement in Connecticut.
The average amount of revenue for each completed 60-day home health episode generated from patients who are receiving care under Medicare reimbursement programs. 30 Table of Contents • Total hospice admissions . Total admissions of hospice patients, including new acquisitions, new admissions and recertifications. • Average hospice daily census .
The average amount of revenue for each completed 60-day home health episode generated from patients who are receiving care under Medicare reimbursement programs. • Total hospice admissions . Total admissions of hospice patients, including new acquisitions, new admissions and recertifications. • Average hospice daily census .
We base our estimates and judgments upon our historical experience, knowledge of current conditions and our belief of what could occur in the future considering available information, including assumptions that we believe to be reasonable under the circumstances.
We base our estimates and judgments upon our historical experience, knowledge of current conditions and our belief 33 Table of Contents of what could occur in the future considering available information, including assumptions that we believe to be reasonable under the circumstances.
We calculate Consolidated Adjusted EBITDA by adjusting Consolidated EBITDA to exclude the effects of non-core business items, which for the reported periods includes, to the extent applicable: • costs at start-up operations; • share-based compensation expense; • acquisition related costs and credit allowances; 39 Table of Contents • costs associated with transitioning operations ; and • unusual or non-recurring charges.
We calculate Consolidated Adjusted EBITDA by adjusting Consolidated EBITDA to exclude the effects of non-core business items, which for the reported periods includes, to the extent applicable: • results at start-up operations; • share-based compensation expense; • acquisition related costs; 39 Table of Contents • activities associated with transitioning operations ; and • unusual, non-recurring, or redundant charges.
(d) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
(d) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 and 2025 which were recorded in gain on disposition of property and equipment, net on the consolidated statements of income.
As a percentage of revenue, costs of service increased by 50 basis points during the year ended December 31, 2024 when compared to the year ended December 31, 2023 primarily due to increased wages and benefits. Rent—Cost of Services .
As a percentage of revenue, costs of service increased by 150 basis points during the year ended December 31, 2025 when compared to the year ended December 31, 2024 primarily due to increased wages and benefits. Rent—Cost of Services .
The following table summarizes our senior living statistics for the periods indicated: Year Ended December 31, 2024 2023 Occupancy 78.8 % 78.5 % Average monthly revenue per occupied unit $ 4,811 $ 4,443 Revenue Sources Home Health and Hospice Services Home Health . We derive the majority of our home health revenue from Medicare and managed care.
The following table summarizes our senior living statistics for the periods indicated: Year Ended December 31, 2025 2024 Occupancy 79.7 % 78.8 % Average monthly revenue per occupied unit $ 5,195 $ 4,811 Revenue Sources Home Health and Hospice Services Home Health . We derive the majority of our home health revenue from Medicare and managed care.
The total admissions of home health patients, including new acquisitions, new admissions and readmissions. • Total Medicare home health admissions . Total admissions of home health patients, who are receiving care under Medicare reimbursement programs, including new acquisitions, new admissions and readmissions. • Average Medicare revenue per completed 60-day home health episode .
Total admissions of home health patients, who are receiving care under Medicare reimbursement programs, including new acquisitions, new admissions and readmissions. 31 Table of Contents • Average Medicare revenue per completed 60-day home health episode .
The increase in the amount of cost of services was driven primarily by volume of services provided and increased wages and benefits. Cost of services as a percentage of revenue decreased by 10 basis points from 80.4% to 80.3% over the same time period.
The increase in the amount of cost of services was driven primarily by volume of services provided and increased wages and benefits. Cost of services as a percentage of revenue increased by 80 basis points from 80.3% to 81.1% over the same time period.
(Gain) loss on asset dispositions and impairment, net is a gain of $0.7 million for the year ended December 31, 2024 compared to a loss of $0.1 million for the year ended December 31, 2023 primarily due to insurance proceeds related to one of our senior living communities. Provision for Income Taxes .
Gain on asset dispositions and impairment, net was $1.0 million for the year ended December 31, 2025 compared to $0.7 million for the year ended December 31, 2024 primarily due to insurance proceeds related to one of our senior living communities. Provision for Income Taxes .
The following table summarizes our affiliated home health and hospice agencies and senior living communities as of: 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Home health and hospice agencies 25 32 39 46 54 63 76 88 95 111 123 Senior living communities 15 36 36 43 50 52 54 54 49 51 57 Senior living units 1,587 3,184 3,184 3,434 3,820 3,963 4,127 4,127 3,500 3,588 3,960 Total number of home health, hospice, and senior living operations 40 68 75 89 104 115 130 142 144 162 180 Recent Activities Acquisitions.
The following table summarizes our affiliated home health and hospice agencies and senior living communities as of: 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Home health and hospice agencies 39 46 54 63 76 88 95 111 123 172 Senior living communities 36 43 50 52 54 54 49 51 57 63 Senior living units 3,184 3,434 3,820 3,963 4,127 4,127 3,500 3,588 3,960 4,428 Total number of home health, hospice, and senior living operations 75 89 104 115 130 142 144 162 180 235 Recent Activities Acquisitions.
Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K filed with the SEC on February 28, 2024. Liquidity and Capital Resources Our primary sources of liquidity are cash generated through operating activities and borrowings under our revolving credit facility.
Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K filed with the SEC on February 27, 2025. Liquidity and Capital Resources Our primary sources of liquidity are cash generated through operating activities and borrowings under our credit agreement.
The increase in general and administrative expense was primarily due to an increase of $12.5 million in wages and benefits for the year ended December 31, 2024 when compared to the year ended December 31, 2023. Depreciation and Amortization.
The increase in general and administrative expense was primarily due to an increase of $18.8 million in wages and benefits for the year ended December 31, 2025 when compared to the year ended December 31, 2024. Depreciation and Amortization.
We believe that our existing cash, cash generated through operations, and access to available borrowing capacity under our Amended Credit Agreement, will be sufficient to provide adequate liquidity for the next twelve months for both our operating activities and opportunities for acquisition growth. 43 Table of Contents The following table presents selected data from our statement of cash flows for the periods presented: Year Ended December 31, 2024 2023 (In thousands) Net cash provided by operating activities $ 39,298 $ 33,090 Net cash used in investing activities (70,684) (30,222) Net cash provided by financing activities 49,573 1,112 Net change in cash 18,187 3,980 Cash at beginning of year 6,059 2,079 Cash at end of year $ 24,246 $ 6,059 Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023 Our net cash flow from operating activities for the year ended December 31, 2024 increased by $6.2 million when compared to the year ended December 31, 2023.
We believe that our existing cash, cash generated through operations, and access to available borrowing capacity under our Amended Credit Agreement, will be sufficient to provide adequate liquidity for the next twelve months for both our operating activities and opportunities for acquisition growth. 43 Table of Contents The following table presents selected data from our statement of cash flows for the periods presented: Year Ended December 31, 2025 2024 (In thousands) Net cash provided by operating activities $ 48,294 $ 39,298 Net cash used in investing activities (227,971) (70,684) Net cash provided by financing activities 172,455 49,573 Net change in cash (7,222) 18,187 Cash at beginning of year 24,246 6,059 Cash at end of year $ 17,024 $ 24,246 Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024 Our net cash flow from operating activities for the year ended December 31, 2025 increased by $9.0 million when compared to the year ended December 31, 2024.
Rent increased 8.2% from $39.8 million to $43.0 million for the year ended December 31, 2024 compared to the year ended December 31, 2023, primarily as a result of the newly acquired senior living communities.
Rent increased 13.2% from $43.0 million to $48.7 million for the year ended December 31, 2025 compared to the year ended December 31, 2024, primarily as a result of the newly acquired senior living communities.
General and administrative expenses are not allocated to the reportable segments, and are included as “All Other”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited. (b) Represents results related to start-up operations.
General and administrative expenses are not allocated to the reportable segments, and are included as “Unallocated corporate expenses”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
During 2024, we expanded our operations with the addition of eight home health agencies, three hospice agencies, and six senior living communities. A subsidiary of the Company entered into a separate purchase agreements with the prior operator of each acquired operation as part of each transaction.
During 2025, we expanded our operations with the addition of 30 home health agencies, nine hospice agencies, four home care agencies, and six senior living communities. A subsidiary of the Company entered into a separate purchase agreements with the prior operator of each acquired operation as part of each transaction. Expansion into New States .
The improvement in these metrics resulted in net organic revenue growth of $46.4 million for the year ended December 31, 2024.
The improvement in these metrics resulted in net organic revenue growth of $52.8 million for the year ended December 31, 2025.
Property and equipment are initially recorded at their historical cost. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from one to 40 years).
Property and equipment are initially recorded at their historical cost. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from one to 40 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.
Performance and Valuation Measures: Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated Non-GAAP Financial Measures: Performance Metrics Consolidated EBITDA $ 42,662 $ 30,107 $ 17,008 Consolidated Adjusted EBITDA $ 53,286 $ 40,716 $ 31,545 Valuation Metric Consolidated Adjusted EBITDAR $ 95,782 Year Ended December 31, 2024 2023 2022 (In thousands) Segment Non-GAAP Measures: (a) Segment Adjusted EBITDA from Operations Home health and hospice services $ 80,660 $ 60,128 $ 56,977 Senior living services $ 16,213 $ 12,293 $ 6,003 (a) General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss. 36 Table of Contents The table below reconciles Consolidated Net Income to Consolidated EBITDA, Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDAR for the periods presented: Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated Net income $ 24,339 $ 13,910 $ 7,243 Less: Net income attributable to noncontrolling interest 1,780 531 600 Add: Provision for income taxes 7,028 5,674 1,649 Net interest expense 6,956 5,924 3,816 Depreciation and amortization 6,119 5,130 4,900 Consolidated EBITDA 42,662 30,107 17,008 Adjustments to Consolidated EBITDA Add: Costs at start-up operations (a) 137 102 1,435 Share-based compensation expense (b) 8,242 5,565 3,363 Acquisition related costs and credit allowances (c) 1,278 476 731 Activities associated with transitioning operations (d) (570) 612 6,103 Unusual or non-recurring charges (e) 1,004 2,575 1,297 Rent related to items (a) and (e) above 533 1,279 1,608 Consolidated Adjusted EBITDA 53,286 40,716 31,545 Rent—cost of services 43,029 39,759 38,018 Rent related to items (a) and (e) above (533) (1,279) (1,608) Adjusted rent—cost of services 42,496 38,480 36,410 Consolidated Adjusted EBITDAR $ 95,782 (a) Represents results related to start-up operations.
Performance and Valuation Measures: Year Ended December 31, 2025 2024 2023 (In thousands) Consolidated Non-GAAP Financial Measures: Performance Metrics Consolidated EBITDA $ 56,660 $ 42,662 $ 30,107 Consolidated Adjusted EBITDA $ 72,466 $ 53,286 $ 40,716 Valuation Metric Consolidated Adjusted EBITDAR $ 120,901 Year Ended December 31, 2025 2024 2023 (In thousands) Segment Non-GAAP Measures: (a) Segment Adjusted EBITDA from Operations Home health and hospice services $ 111,135 $ 80,660 $ 60,128 Senior living services $ 21,785 $ 16,213 $ 12,293 (a) General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss. 36 Table of Contents The table below reconciles Consolidated Net Income to Consolidated EBITDA, Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDAR for the periods presented: Year Ended December 31, 2025 2024 2023 (In thousands) Consolidated Net income $ 33,764 $ 24,339 $ 13,910 Less: Net income attributable to noncontrolling interest 4,186 1,780 531 Add: Provision for income taxes 11,866 7,028 5,674 Net interest expense 6,678 6,956 5,924 Depreciation and amortization 8,538 6,119 5,130 Consolidated EBITDA 56,660 42,662 30,107 Adjustments to Consolidated EBITDA Add: Start-up operations (a) 182 137 102 Share-based compensation expense (b) 9,036 8,242 5,565 Acquisition related costs (c) 6,587 1,278 476 Activities associated with transitioning operations (d) (880) (570) 612 Transition services costs (e) 503 — — Unusual, non-recurring, or redundant charges (f) 113 1,004 2,575 Rent related to items (a) and (e) above 265 533 1,279 Consolidated Adjusted EBITDA 72,466 53,286 40,716 Rent—cost of services 48,700 43,029 39,759 Rent related to items (a) and (e) above (265) (533) (1,279) Adjusted rent—cost of services 48,435 42,496 38,480 Consolidated Adjusted EBITDAR $ 120,901 (a) Represents results related to start-up operations.
Growth was also driven by the acquisition of eleven home health and hospice operations during the year ended December 31, 2024, and the acquisition of thirteen home health, home care, and hospice operations during the year ended December 31, 2023, resulting in an increase in revenue of $78.6 million, or 19.9% overall.
Growth was also driven by the acquisition of forty-three home health, home care and hospice operations during the year ended December 31, 2025, and the acquisition of eleven home health, home care, and hospice operations during the year ended December 31, 2024, resulting in an increase in revenue of $160.5 million, or 30.9% overall.
As of December 31, 2024, our home health and hospice business provided home health, hospice and 29 Table of Contents home care services from 123 agencies operating across 13 states, and our senior living business operated 57 senior living communities throughout seven states.
As of December 31, 2025, our home health and hospice business provided 30 Table of Contents home health, hospice and home care services from 172 agencies operating across 16 states, and our senior living business operated 63 senior living communities throughout seven states.
Senior Living Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Cost of service $ 124,975 $ 106,252 $ 18,723 17.6 % Cost of services as a percentage of revenue 71.1 % 70.6 % 0.5 % Cost of services related to our Senior Living services segment increased $18.7 million, or 17.6%, during the year ended December 31, 2024 in response to higher occupancy, acquisitions and wage rate increases.
Senior Living Services Year Ended December 31, 2025 2024 Change % Change (In thousands) Cost of service $ 156,043 $ 124,975 $ 31,068 24.9 % Cost of services as a percentage of revenue 72.6 % 71.1 % 1.5 % Cost of services related to our Senior Living services segment increased $31.1 million, or 24.9%, during the year ended December 31, 2025 in response to higher occupancy, acquisitions and wage rate increases.
Home Health and Hospice Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Cost of service $ 433,474 $ 331,844 $ 101,630 30.6 % Cost of services as a percentage of revenue 83.4 % 84.1 % (0.7) % Cost of services related to our Home Health and Hospice services segment increased $101.6 million, or 30.6%, primarily due to increased volume of services from the growth in admissions and average daily census as well as increased wages and benefits.
Home Health and Hospice Services Year Ended December 31, 2025 2024 Change % Change (In thousands) Cost of service $ 612,460 $ 433,474 $ 178,986 41.3 % Cost of services as a percentage of revenue 83.6 % 83.4 % 0.2 % Cost of services related to our Home Health and Hospice services segment increased $179.0 million, or 41.3%, primarily due to increased volume of services from the growth in admissions and average daily census as well as increased wages and benefits.
The primary drivers of this difference was a $10.4 million increase in net income, offset by a $2.5 million net decrease in cash flows from the change in operating assets and liabilities and a net decrease of $1.7 million in non-cash expenses.
The primary drivers of this difference were a $9.4 million increase in net income and a $2.5 million net decrease in cash flows from the change in operating assets and liabilities.
Recent Accounting Pronouncements Information concerning recently issued accounting pronouncements which are not yet effective is included in Note 2, Basis of Presentation and Summary of Significant Accounting Policies in the Consolidated Financial Statements. 33 Table of Contents Results of Operations The following table sets forth details of our expenses and earnings as a percentage of total revenue for the periods indicated: Year Ended December 31, 2024 2023 2022 Total revenue 100.0 % 100.0 % 100.0 % Expense: Cost of services 80.3 80.4 79.6 Rent—cost of services 6.2 7.3 8.0 General and administrative expense 7.2 6.7 7.2 Depreciation and amortization 0.9 0.9 1.0 (Gain) loss on asset dispositions and impairment, net (0.1) — 1.5 Total expenses 94.5 95.3 97.3 Income from operations 5.5 4.7 2.7 Other expense, net: Other income — 0.1 — Interest expense, net (1.0) (1.2) (0.8) Other expense, net (1.0) (1.1) (0.8) Income before provision for income taxes 4.5 3.6 1.9 Provision for income taxes 1.0 1.0 0.4 Net income 3.5 2.6 1.5 Less: net income attributable to noncontrolling interest 0.3 0.1 0.1 Net income attributable to Pennant 3.2 % 2.5 % 1.4 % Year Ended December 31, 2024 2023 2022 (In thousands) Consolidated GAAP Financial Measures: Total revenue $ 695,240 $ 544,891 $ 473,241 Total expenses 657,124 519,722 460,502 Income from operations $ 38,116 $ 25,169 $ 12,739 34 Table of Contents The following table presents certain financial information regarding our reportable segments.
Results of Operations The following table sets forth details of our expenses and earnings as a percentage of total revenue for the periods indicated: Year Ended December 31, 2025 2024 2023 Total revenue 100.0 % 100.0 % 100.0 % Expense: Cost of services 81.1 80.3 80.4 Rent—cost of services 5.1 6.2 7.3 General and administrative expense 7.5 7.2 6.7 Depreciation and amortization 0.9 0.9 0.9 Gain on asset dispositions and impairment, net (0.1) (0.1) — Total expenses 94.5 94.5 95.3 Income from operations 5.5 5.5 4.7 Other expense, net: Other income — — 0.1 Interest expense, net (0.7) (1.0) (1.2) Other expense, net (0.7) (1.0) (1.1) Income before provision for income taxes 4.8 4.5 3.6 Provision for income taxes 1.2 1.0 1.0 Net income 3.6 3.5 2.6 Less: net income attributable to noncontrolling interest 0.5 0.3 0.1 Net income attributable to Pennant 3.1 % 3.2 % 2.5 % 34 Table of Contents Year Ended December 31, 2025 2024 2023 (In thousands) Consolidated GAAP Financial Measures: Total revenue $ 947,705 $ 695,240 $ 544,891 Total expenses 895,819 657,124 519,722 Income from operations $ 51,886 $ 38,116 $ 25,169 The following table presents certain financial information regarding our reportable segments.
Revenue grew due to an increase in almost all key performance indicators including an increase in total home health admissions of 37.3%, an increase in Medicare home health admissions of 26.9%, an increase in average Medicare revenue per 60-day completed episode of 6.0%, an increase of 25.3% in total hospice admissions, and an increase of 25.4% in hospice average daily census, while Hospice Medicare revenue per day decreased by 1.1%.
Revenue grew due to an increase in all key performance indicators including an increase in total home health admissions of 44.1%, an increase in Medicare home health admissions of 41.8%, an increase in average Medicare revenue per 60-day completed episode of 3.5%, an increase of 24.4% in total hospice admissions, and an increase of 28.6% in hospice average daily census, and an increase in Hospice Medicare revenue per day of 4.9%.
Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (c) Non-capitalizable costs associated with acquisitions and credit allowances for amounts in dispute with the prior owners of certain acquired operations.
This amount excludes rent and depreciation and amortization expense related to such operations. (b) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (c) Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations.
Our net cash used in investing activities for the year ended December 31, 2024 increased by $40.5 million compared to the year ended December 31, 2023, primarily driven by a $40.4 million increase in business acquisitions, asset acquisitions, and escrow deposits during the year ended December 31, 2024 compared to the year ended December 31, 2023.
Our net cash used in investing activities for the year ended December 31, 2025 increased by $157.3 million compared to the year ended December 31, 2024, primarily driven by a $154.7 million increase in business acquisitions, asset acquisitions, and escrow deposits and a $3.0 million increase in purchases of property and equipment during the year ended December 31, 2025 compared to the year ended December 31, 2024.
The following table summarizes our overall home health and hospice services statistics for the periods indicated: Year Ended December 31, 2024 2023 Home health services: Total home health admissions 59,741 43,508 Total Medicare home health admissions 24,598 19,389 Average Medicare revenue per completed 60-day home health episode (a) $ 3,677 $ 3,468 Hospice services: Total hospice admissions 12,208 9,746 Average hospice daily census 3,268 2,607 Hospice Medicare revenue per day $ 183 $ 185 (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
The following table summarizes our overall home health and hospice services statistics for the periods indicated: Year Ended December 31, 2025 2024 Home health services: Total home health admissions 86,076 59,741 Total Medicare home health admissions 34,882 24,598 Average Medicare revenue per completed 60-day home health episode (a) $ 3,755 $ 3,628 Hospice services: Total hospice admissions 15,189 12,208 Average hospice daily census 4,204 3,268 Hospice Medicare revenue per day $ 192 $ 183 (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. The following are the four levels of care provided under the hospice benefit: • Routine Home Care (RHC).
Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. CMS has established a two-tiered payment system for RHC.
General and administrative expense increased $13.5 million, or 36.9%, from $36.7 million to $50.2 million for the year ended December 31, 2024 when compared to the year ended December 31, 2023.
General and administrative expense increased $20.9 million, or 41.6%, from $50.2 million to $71.1 million for the year ended December 31, 2025 when compared to the year ended December 31, 2024.
The valuation methods and assumptions used in estimating costs up to retention amounts to settle open claims of insureds and an estimate of the cost of insured claims up to retention amounts that have been incurred but not reported; • Revenue recognition - The amounts owed by private pay individuals for services and estimate of variable considerations to arrive at the transaction price, including methods and assumptions, used to determine settlements with Medicare and Medicaid adjustments due to audits and reviews; and • Acquisition accounting and goodwill - The assumptions used to allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions, and the review of goodwill for impairment at the Company’s annual impairment test date or upon the occurrence of a triggering event.
We develop information about the size of the ultimate claims based on historical experience, current industry information, and actuarial analysis; • Revenue recognition - The amounts owed by private pay individuals for services and estimate of variable considerations to arrive at the transaction price, including methods and assumptions, used to determine settlements with Medicare and Medicaid adjustments due to audits and reviews; and • Acquisition accounting and goodwill - The assumptions used to allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions, and the review of goodwill for impairment at the Company’s annual impairment test date or upon the occurrence of a triggering event.
Cost of services as a percentage of revenue for the year ended December 31, 2024 decreased by 70 basis points compared to the year ended December 31, 2023 primarily due to increased efficiency in our operations.
Cost of services as a percentage of revenue for the year ended December 31, 2025 increased by 20 basis points compared to the year ended December 31, 2024 primarily due to increased wages and benefits.
Senior Living Services Year Ended December 31, 2024 2023 Change % Change Revenue (in thousands) $ 175,756 $ 150,427 $ 25,329 16.8 % Number of communities at period end 57 51 6 11.8 Occupancy 78.8 % 78.5 % 0.3 % Average monthly revenue per occupied unit $ 4,811 $ 4,443 $ 368 8.3 % Senior living revenue increased $25.3 million, or 16.8%, for the year ended December 31, 2024 when compared to the same period in the prior year primarily due to a 8.3% increase in average monthly revenue per occupied unit and a 0.3% increase in occupancy rate.
Senior Living Services Year Ended December 31, 2025 2024 Change % Change Revenue (in thousands) $ 214,978 $ 175,756 $ 39,222 22.3 % Number of communities at period end 63 57 6 10.5 Occupancy 79.7 % 78.8 % 0.9 % Average monthly revenue per occupied unit $ 5,195 $ 4,811 $ 384 8.0 % Senior living revenue increased $39.2 million, or 22.3%, for the year ended December 31, 2025 when compared to the same period in the prior year primarily due to an 8.0% increase in average monthly revenue per occupied unit and a 90 basis point increase in occupancy rate.
As of December 31, 2024 we had $24.2 million of cash and $245.8 million of available borrowing capacity on our Amended Revolving Credit Facility.
As of December 31, 2025 we had $17.0 million of cash and $171.6 million of available borrowing capacity on our Amended Revolving Credit Facility.
The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense. 37 Table of Contents The table below reconciles Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for the periods presented: Year Ended December 31, Home Health and Hospice Senior Living 2024 2023 2022 2024 2023 2022 (In thousands) Segment Adjusted EBITDAR from Operations $ 87,709 $ 65,606 $ 61,827 $ 51,660 $ 45,294 $ 37,563 Less: Rent—cost of services 7,189 5,791 5,060 35,840 33,967 32,958 Rent related to start-up and transitioning operations (140) (313) (210) (393) (966) (1,398) Segment Adjusted EBITDA from Operations $ 80,660 $ 60,128 $ 56,977 $ 16,213 $ 12,293 $ 6,003 The following discussion includes references to certain performance and valuation measures, which are non-GAAP financial measures, including Consolidated EBITDA, Consolidated Adjusted EBITDA, Segment Adjusted EBITDA from Operations, and Consolidated Adjusted EBITDAR (collectively, “Non-GAAP Financial Measures”).
(f) Represents unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. 37 Table of Contents The table below reconciles Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for the periods presented: Year Ended December 31, Home Health and Hospice Senior Living 2025 2024 2023 2025 2024 2023 (In thousands) Segment Adjusted EBITDAR from Operations $ 120,831 $ 87,709 $ 65,606 $ 60,525 $ 51,660 $ 45,294 Less: Rent—cost of services 9,752 7,189 5,791 38,949 35,840 33,967 Rent related to start-up and transitioning operations (56) (140) (313) (209) (393) (966) Segment Adjusted EBITDA from Operations $ 111,135 $ 80,660 $ 60,128 $ 21,785 $ 16,213 $ 12,293 The following discussion includes references to certain performance and valuation measures, which are non-GAAP financial measures, including Consolidated EBITDA, Consolidated Adjusted EBITDA, Segment Adjusted EBITDA from Operations, and Consolidated Adjusted EBITDAR (collectively, “Non-GAAP Financial Measures”).
Growth in revenue was also driven by the acquisition of six senior living communities during the year ended December 31, 2024, and the acquisition of two senior living communities during the year ended December 31, 2023, resulting in an increase of $12.5 million, or 8.3% overall. 41 Table of Contents Cost of Services The following table sets forth total cost of services by each of our reportable segments for the periods indicated: Year Ended December 31, 2024 2023 Change % Change (In thousands) Home Health and Hospice $ 433,474 $ 331,844 $ 101,630 30.6 % Senior Living 124,975 106,252 18,723 17.6 Total cost of services $ 558,449 $ 438,096 $ 120,353 27.5 % Consolidated cost of services increased $120.4 million, or 27.5%, for the year ended December 31, 2024 when compared to the year ended December 31, 2023.
Growth in revenue was also driven by the acquisition of six senior living communities during the year ended December 31, 2025, and the acquisition of six senior living communities during the year ended December 31, 2024, resulting in an increase of $24.6 million, or 14.0% overall. 41 Table of Contents Cost of Services The following table sets forth total cost of services by each of our reportable segments for the periods indicated: Year Ended December 31, 2025 2024 Change % Change (In thousands) Home Health and Hospice $ 612,460 $ 433,474 $ 178,986 41.3 % Senior Living 156,043 124,975 31,068 24.9 Total cost of services $ 768,503 $ 558,449 $ 210,054 37.6 % Consolidated cost of services increased $210.1 million, or 37.6%, for the year ended December 31, 2025 when compared to the year ended December 31, 2024.
Our effective tax rate for the year ended December 31, 2024 was 22.4% of earnings before income taxes compared with an effective tax rate of 29.0% for the year ended December 31, 2023. The decrease in the effective tax rate is primarily due to a change in deductible equity compensation expenses.
Our effective tax rate for the year ended December 31, 2025 was 26.0% of earnings before income taxes compared with an effective tax rate of 22.4% for the year ended December 31, 2024. The increase in the effective tax rate is primarily driven by the change in discrete tax effects of share-based compensation.
Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023 Revenue Year Ended December 31, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage (In thousands) Home health and hospice services Home health $ 239,539 34.5 % $ 175,044 32.1 % Hospice 240,102 34.5 194,627 35.7 Home care and other (a) 39,843 5.7 24,793 4.6 Total home health and hospice services 519,484 74.7 394,464 72.4 Senior living services 175,756 25.3 150,427 27.6 Total revenue $ 695,240 100.0 % $ 544,891 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this report.
Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024 Revenue Year Ended December 31, 2025 2024 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage (In thousands) Home health and hospice services Home health $ 351,240 37.1 % $ 239,539 34.5 % Hospice 317,801 33.5 240,102 34.5 Home care and other (a) 63,686 6.7 39,843 5.7 Total home health and hospice services 732,727 77.3 519,484 74.7 Senior living services 214,978 22.7 175,756 25.3 Total revenue $ 947,705 100.0 % $ 695,240 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this report.
Home health and hospice revenue increased $125.0 million, or 31.7%.
Home health and hospice revenue increased $213.2 million, or 41.0%.
Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term. 32 Table of Contents Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Our consolidated revenue increased $150.3 million, or 27.6%, driven by the net organic growth of existing operations across all segments of $59.2 million or 10.9% as well as increased revenue from acquired operations of $91.1 million, or 16.7%, during the year ended December 31, 2024. 40 Table of Contents Home Health and Hospice Services Year Ended December 31, 2024 2023 Change % Change (In thousands) Home health and hospice revenue Home health services $ 239,539 $ 175,044 $ 64,495 36.8 % Hospice services 240,102 194,627 45,475 23.4 Home care and other 39,843 24,793 15,050 60.7 Total home health and hospice revenue $ 519,484 $ 394,464 $ 125,020 31.7 % Year Ended December 31, 2024 2023 Change % Change Home health services: Total home health admissions 59,741 43,508 16,233 37.3 % Total Medicare home health admissions 24,598 19,389 5,209 26.9 Average Medicare revenue per 60-day completed episode (a) $ 3,677 $ 3,468 $ 209 6.0 Hospice services: Total hospice admissions 12,208 9,746 2,462 25.3 Average daily census 3,268 2,607 661 25.4 Hospice Medicare revenue per day $ 183 $ 185 $ (2) (1.1) Number of home health and hospice agencies at period end 123 111 12 10.8 % (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
Our consolidated revenue increased $252.5 million, or 36.3%, driven by the net organic growth of existing operations across all segments of $67.5 million or 9.7% as well as increased revenue from acquired operations of $185.0 million, or 26.6%, during the year ended December 31, 2025. 40 Table of Contents Home Health and Hospice Services Year Ended December 31, 2025 2024 Change % Change (In thousands) Home health and hospice revenue Home health services $ 351,240 $ 239,539 $ 111,701 46.6 % Hospice services 317,801 240,102 77,699 32.4 Home care and other 63,686 39,843 23,843 59.8 Total home health and hospice revenue $ 732,727 $ 519,484 $ 213,243 41.0 % Year Ended December 31, 2025 2024 Change % Change Home health services: Total home health admissions 86,076 59,741 26,335 44.1 % Total Medicare home health admissions 34,882 24,598 10,284 41.8 Average Medicare revenue per 60-day completed episode (a) $ 3,755 $ 3,628 $ 127 3.5 Hospice services: Total hospice admissions 15,189 12,208 2,981 24.4 Average daily census 4,204 3,268 936 28.6 Hospice Medicare revenue per day $ 192 $ 183 $ 9 4.9 Number of home health and hospice agencies at period end 172 123 49 39.8 % (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
The amounts reported exclude rent and depreciation and amortization expense related to such operations. (f) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(g) Represents unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
Our Chief Executive Officer, who is our Chief Operating Decision Maker (“CODM”), reviews financial information at the operating segment level using segment adjusted EBITDAR from operations. We also report an “all other” category that includes general and administrative expense from our Service Center.
Our Chief Executive Officer, who is our Chief Operating Decision Maker (“CODM”), reviews financial information at the operating segment level using segment adjusted EBITDAR from operations. Key Performance Indicators We manage the fiscal aspects of our business by monitoring key performance indicators that affect our financial performance.
CMS also provided for a Service Intensity Add-On, which increases payments for certain RHC services provided by registered nurses and social workers to hospice patients during the final seven days of life. Medicare reimbursement is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to the payor and other reasons unrelated to credit risk.
Hospices are reimbursed at a higher rate for RHC services provided from days of service 1 through 60 and a lower rate for all subsequent days of service. CMS also provided for a Service Intensity Add-On, which increases payments for certain RHC services provided by registered nurses and social workers to hospice patients during the final seven days of life.
The amounts reported for the year ended December 31, 2022 include certain costs identified as redundant or non-recurring incurred by the Company for services provided by Ensign under the Transition Services Agreement, and were included in general and administrative expense.
(f) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth entered into as part of the acquisition agreement. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $3,001 for the year ended December 31, 2025.
Key Performance Indicators We manage the fiscal aspects of our business by monitoring key performance indicators that affect our financial performance. These indicators and their definitions include the following: Home Health and Hospice Services • Total home health admissions .
These indicators and their definitions include the following: Home Health and Hospice Services • Total home health admissions . The total admissions of home health patients, including new acquisitions, new admissions and readmissions. • Total Medicare home health admissions .
This amount excludes rent and depreciation and amortization expense related to such operations. (c) Share-based compensation expense and related payroll taxes incurred, including the impact of the modification of certain restricted stock units described below in Note 12, Options and Awards, to the Consolidated Financial Statements.
(b) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations. (c) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
(d) Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations. (e) During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community.
The amounts reported exclude rent and depreciation and amortization expense related to such operations. (e) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
The amounts reported exclude rent and depreciation and amortization expense related to such operations. (e) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth entered into as part of the acquisition agreement. All amounts are included in Cost of services.
Although we saw steady improvements in occupancy throughout 2023 as a result of renewed consideration of senior living communities as the negative impacts of the global pandemic subsided, and stable occupancy during 2024, the highly competitive environment for senior living residents and inflationary factors will continue to impact our occupancy levels in our senior living communities.
Though we have seen improvements in revenue per occupied unit and occupancy year over year, the highly competitive environment for senior living residents and inflationary factors will continue to impact the rate at which our revenue per occupied unit and occupancy levels change in our senior living communities.
Our net cash provided by financing activities increased by $48.5 million for the year ended December 31, 2024 when compared to the year ended December 31, 2023 primarily due to an issuance of equity through a secondary offering totaling $118.1 million offset by a net repayment of debt totaling $65.0 million and payments for deferred financing costs of $3.9 million during the year ended December 31, 2024.
Our net cash provided by financing activities increased by $122.9 million for the year ended December 31, 2025 when compared to the year ended December 31, 2024, primarily driven by an increase in net proceeds from our Amended Revolving Credit Facility of $140.0 million and an increase in proceeds from our Incremental Term Loans of $100.0 million.